MINNEAPOLIS, Minnesota, USA - (June 8, 2012) - QRS Diagnostic, a software-based medical device manufacturer, announces the release of the Q200/HE Combination Holter/Event Digital Recorder.
The Q200/HE is the newest device from QRS to enter the market. It is a combination 14-day Holter monitor plus 30-day event recorder. The Q200/HE interfaces with Holter LX Analysis software to capture elusive cardiac events, deliver fast and accurate analysis and provide customizable reports.
The Q200/HE allows for patients to be monitored and cardiac data to be gathered outside the clinic. Holter/Event monitoring allows for evaluation of chest pain, effectiveness of treatment, arrhythmias found on resting ECGs and diagnosing atrial fibrillation, multifocal atrial tachycardia, palpitations and more. The accurate and reliable digital technology in the Q200/HE allows for enhanced and supplementary data collection and analysis aiding in accurate patient diagnosis and treatment.
Holter LX Analysis Software is available in four levels - Basic, Enhanced, Enhanced Plus and Pro - each level providing varying capabilities based on customer needs. The Q200/HE interfaces with Holter LX Analysis to view, interpret, analyze and report gathered data. The Holter LX Analysis software is available in English, French, German, Spanish, Portuguese, Italian, Turkish and Polish.
QRS is proud to announce the release of the Q200/HE, the third of three new products from QRS. Timothy Lebens, Vice President Sales and Marketing at QRS, said, "The Q200/HE is a market-leading, combination recorder which is rare in the medical industry. This device, combined with the Holter LX Analysis, best-in-class software, will be a market breakthrough, winning product."
The Q200/HE is CE Marked and has US FDA 510(k) clearance, Canadian and Australian approvals.
For additional information about the Q200/HE and other holter/event monitoring products QRS offers, please visit www.QRSdiagnostic.com/holter.